Synthetic Review

Synthetic engineering is going to outdo genetic engineering, predicts this Week in Review article from the New York Times. Right now, the field is in its infancy and is merely copying life rather than creating it from scratch, says the article, but a major potential application is bioenergy -- and a major concern is bioterrorism.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.